Edwards Lifesciences Corp

LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA EW

Report date

3/31/2026

Quarter

2026 Q1

Filed

4/13/2026

Shares

29,737

Value ($000)

2,316

Weight

0.0%

2014 Q1 - 2026 Q1 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	4/13/2026	2,316	0.0%	29,737	3/31/2026
2025 Q4	1/28/2026	2,486	0.0%	29,737	12/31/2025
2025 Q3	10/24/2025	2,660	0.0%	34,757	9/30/2025
2025 Q2	7/30/2025	2,888	0.0%	36,927	6/30/2025
2025 Q1	4/24/2025	2,952	0.0%	41,893	3/31/2025
2024 Q4	1/28/2025	3,696	0.0%	53,412	12/31/2024
2024 Q3	10/25/2024	4,158	0.0%	59,098	9/30/2024
2024 Q2	7/17/2024	9,286	0.1%	105,844	6/30/2024
2024 Q1	4/23/2024	11,592	0.1%	133,302	3/31/2024
2023 Q4	2/1/2024	14,587	0.1%	185,891	12/31/2023
2023 Q3	11/3/2023	30,471	0.3%	464,986	9/30/2023
2023 Q2	8/1/2023	83,483	0.9%	885,013	6/30/2023
2023 Q1	5/2/2023	77,676	0.9%	938,910	3/31/2023
2022 Q4	3/2/2023	72,413	0.9%	970,548	12/31/2022
2022 Q3	10/25/2022	80,994	1.1%	980,202	9/30/2022
2022 Q2	7/26/2022	91,904	1.1%	966,493	6/30/2022
2022 Q1	4/13/2022	113,593	1.2%	964,943	3/31/2022
2021 Q4	2/14/2022	124,732	1.1%	962,803	12/31/2021
2021 Q3	11/12/2021	110,902	1.1%	979,613	9/30/2021
2021 Q2	8/13/2021	101,199	1.0%	977,111	6/30/2021
2021 Q1	4/14/2021	81,862	0.9%	978,741	3/31/2021
2020 Q4	1/14/2021	88,260	1.0%	967,447	12/31/2020
2020 Q3	10/15/2020	65,618	0.8%	822,073	9/30/2020
2020 Q2	7/30/2020	34,851	0.5%	504,288	6/30/2020
2020 Q1	4/15/2020	17,813	0.3%	94,439	3/31/2020
2019 Q4	1/22/2020	21,161	0.3%	90,707	12/31/2019
2014 Q1	4/28/2014	11	0.0%	150	3/31/2014